Below are the most recent publications written about "Cytokines" by people in Profiles.
-
Chen S, Putnik R, Li X, Diwaker A, Vasconcelos M, Liu S, Gondi S, Zhou J, Guo L, Xu L, Temme S, Bersch K, Hyland S, Yin J, Burstein E, Bahnson BJ, Gildersleeve JC, Grimes CL, Reinecker HC. PGLYRP1-mediated intracellular peptidoglycan detection promotes intestinal?mucosal protection. Nat Commun. 2025 Feb 21; 16(1):1864.
-
von Stade D, Meyers M, Johnson J, Schlegel T, Romeo A, Regan D, McGilvray K. Primary Human Macrophage and Tenocyte Tendon Healing Phenotypes Changed by Exosomes Per Cell Origin. Tissue Eng Part A. 2025 Aug; 31(15-16):1109-1120.
-
Azizi G, Van den Broek B, Ishikawa LLW, Naziri H, Yazdani R, Zhang GX, Ciric B, Rostami A. IL-7Ra on CD4+ T cells is required for their survival and the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2024 Oct 08; 21(1):253.
-
Buchheit KM, Shaw D, Chupp G, Lehtimaki L, Heffler E, Finney-Hayward T, Zangrilli J, Kwiatek J, Siddiqui S, Roufosse F, Thamboo A, West N, Vichiendilokkul A, Hellings PW, Peters A, Howarth PH. Interleukin-5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils. Allergy. 2024 Oct; 79(10):2662-2679.
-
Diorio C, Hernandez-Miyares L, Espinoza DA, Banwell BL, Bar-Or A, DiNofia AM, Barz Leahy A, Martinez Z, Myers RM, Hopkins SE, Rheingold SR, Teachey DT, Viaene AN, Wray LM, Maude SL, Grupp SA, McGuire JL. Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood. 2024 09 26; 144(13):1387-1398.
-
Guo ZF, Tongmuang N, Li C, Zhang C, Hu L, Capreri D, Zuo MX, Summer R, Sun J. Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. JCI Insight. 2024 Sep 10; 9(17).
-
Fitzpatrick AM, Mohammad AF, Desher K, Mutic AD, Stephenson ST, Dallalio GA, Grunwell JR. Clinical and inflammatory features of traffic-related diesel exposure in children with asthma. Ann Allergy Asthma Immunol. 2024 Oct; 133(4):393-402.e4.
-
Lacouture ME, Goleva E, Shah N, Rotemberg V, Kraehenbuehl L, Ketosugbo KF, Merghoub T, Maier T, Bang A, Gu S, Salvador T, Moy AP, Lyubchenko T, Xiao O, Hall CF, Berdyshev E, Crooks J, Weight R, Kern JA, Leung DYM. Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways. Clin Cancer Res. 2024 Jul 01; 30(13):2822-2834.
-
Alnemri AE, Tekumalla S, Moroco AE, Vathiotis I, Tuluc M, Gargano S, Zhan T, Cognetti DM, Curry JM, Argiris A, Linnenbach A, South AP, Harshyne LA, Johnson JM, Luginbuhl AJ. Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma. Cancer Med. 2024 Jun; 13(11):e7370.
-
Salamanna F, Faldini C, Veronesi F, Borsari V, Ruffilli A, Manzetti M, Viroli G, Traversari M, Marchese L, Fini M, Giavaresi G. A Pilot Study on Circulating, Cellular, and Tissue Biomarkers in Osteosarcopenic Patients. Int J Mol Sci. 2024 May 28; 25(11).